Evaluation of the effects of isoproterenol on arrhythmia recurrence following catheter ablation in patients with atrioventricular nodal re-entrant tachycardia: A randomized controlled clinical trial.

Pharmacol Res Perspect · 2023 · PMC9975462 · PMID 36855813

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might be significantno p-value reported

Therefore, the non‐statistically significant difference between the isoproterenol and control group may be due to the inadequate sample size, and the results might be significant in a higher sample size.

also in 2,435 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.